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Summary
Focal adhesion kinase (FAK) is a critical mediator of matrix- and growth factor-induced signaling
during development. Myocyte-restricted FAK deletion in mid-gestation mice results in impaired
ventricular septation and cardiac compaction. However, whether FAK regulates early cardiogenic
steps remains unknown. To explore a role for FAK in multi-chambered heart formation, we
utilized anti-sense morpholinos to deplete FAK in Xenopus laevis. Xenopus FAK morphants
exhibited impaired cardiogenesis, pronounced pericardial edema, and lethality by tadpole stages.
Spatial-temporal assessment of cardiac marker gene expression revealed that FAK was not
necessary for midline migration, differentiation, fusion of cardiac precursors, or linear heart tube
formation. However, myocyte proliferation was significantly reduced in FAK morphant heart
tubes and these tubes failed to undergo proper looping morphogenesis. Collectively our data imply
that FAK plays an essential role in chamber outgrowth and looping morphogenesis likely
stimulated by fibroblast growth factors (and possibly other) cardiotrophic factors.
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INTRODUCTION
Heart formation involves an intricate and complex series of events that must occur in a
coordinated spatial and temporal manner. The heart develops from bilaterally symmetric
cardiogenic primordia that migrate and fuse at the embryonic midline, proliferate, and form
a primitive heart tube (Dehaan, 1963; Goetz and Conlon, 2007; Kolker et al., 2000; Mohun
et al., 2000, 2003; Trinh and Stainier, 2004a). In species with multichambered hearts the
primitive heart tube rapidly undergoes looping morphogenesis and maturation to form a
fully functioning heart with outflow tracts aligned with the vasculature.
Appropriate cardiac morphogenesis requires regional coordinated recruitment,
differentiation, and proliferation of cardiomyocytes. A large body of evidence indicates that
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signals secreted from the endoderm including soluble factors (e.g., fibroblast growth factors
(FGFs), bone morphogenic proteins (BMPs) and extracellular matrix (ECM) proteins (e.g.,
fibronectin) are prominent inducers of the cardiogenic field (Ahuja et al., 2007; Chen et al.,
2004; Choi et al., 2007; Lavine and Ornitz, 2008; Lavine et al., 2005). Via incompletely
understood mechanisms, these signals induce the expression of critical myocardial
transcription factors in discrete (often chamber-specific) locales. Notably, genetic studies in
chick, zebrafish, frogs, and mice have revealed that spatiotemporal induction of myocyte
enhancement factor 2 (MEF2) and GATA factors are necessary for regulated myocyte
differentiation, while Nkx2.5, Tbx2, and Tbx3 are required for coordinating myocyte
proliferation (Moorman and Christoffels, 2003; Srivastava and Olson, 2000; Zaffran and
Frasch, 2002).
The non-receptor tyrosine kinase, focal adhesion kinase (FAK) is strongly activated by
fibronectin-binding integrins (α5β1) and growth factors (Parsons, 2003) and is a likely
candidate to integrate downstream signals from these diverse pathways during myocardial
development. Indeed, studies by our group and others have indicated that myocyte-specific
depletion of FAK (or inactivation of FAK) leads to early embryonic lethality associated with
left ventricular noncompaction (DiMichele et al., 2009; Peng et al., 2008). Although these
studies highlight an essential role for FAK during mid-gestational cardiac growth, a
limitation of these studies is that FAK signaling is not significantly depleted in these hearts
until embryonic day 13.5 (E13.5) or later, precluding determination of whether FAK activity
is necessary for earlier stages of cardiac morphogenesis. Importantly, FAK is expressed in
the mouse mesoderm prior to cardiogenesis (E7.5) and germ-line deletion of FAK in the
mouse induces a variety of mesodermal defects and early embryonic death within a time
frame either prior to or during looping morphogenesis (between E8.5-10.5 in mice) (Furuta
et al., 1995). In stark contrast, depletion of the FAK ortholog FAK56 in Drosophila does not
affect viability of this organism and no defects in heart formation were reported (Grabbe et
al., 2004). Since the Drosophila heart consists of a linear tube that does not undergo the
marked morphological changes that occur during multichambered heart formation, we
speculated that looping morphogenesis may be a key developmental process regulated by
FAK in higher organisms.
To study the possible requirement for FAK in this intricate morphogenetic event, we
depleted FAK in Xenopus laevis by microinjection of inhibitory antisense morpholino
oligonucleotides. This model system is particularly suited to studying cardiac development
because of the ease of temporal analysis of morphogenetic events and because Xenopus do
not require heart function to survive (at least until the late tadpole stage of development)
since nutrient exchange readily occurs by diffusion. Herein, we show that FAK-depleted
tadpoles exhibit abnormal myocardial morphogenesis accompanied by pericardial edema
and early embryonic lethality. Our mechanistic studies reveal that FAK activation, likely by
FGFs, facilitates myocyte proliferation in the prelooped heart tube, thus contributing to the
complex process of looping morphogenesis.
RESULTS
Inhibition of FAK by Morpholino-Injection
FAK plays a critical function in murine development and is necessary for myocardial
compaction. However, no studies to date have addressed a specific role for FAK in early
cardiac development, specifically in regulating cardiac morphogenesis (DiMichele et al.,
2009; Furuta et al., 1995; Peng et al., 2008). To study the time-dependent requirements for
FAK during this intricate process, we depleted FAK protein in Xenopus, which develop a
fully functioning three-chambered heart by 72 h post-fertilization. To this end, we designed
two FAK-specific antisense morpholinos to target sequences either upstream of, or flanking,
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the start codon of Xenopus fak (denoted FAK Mo and xFAKst, respectively). Both
morpholinos significantly reduced flag-tagged FAK protein production in an in vitro
transcription/translation assay, with FAK Mo being slightly more potent (data not shown).
To establish that FAK Mo effectively blocks FAK translation in vivo, we injected standard
quantities (20 and 40 ng) into single-cell fertilized Xenopus embryos. Western blot analysis
of stage 22, 26, and 39 embryos confirmed that FAK protein levels were reduced in a dose-
dependent manner (Fig. 1A). We next performed further temporal analysis of FAK levels
during development in embryos injected with 40 ng of either control morpholino (Con Mo)
or FAK Mo. As previously reported, we found that a low level of maternal FAK was
apparent in fertilized eggs which persisted throughout the onset of gastrulation (stage 10.5)
at which time embryonic FAK protein was markedly induced (Hens and DeSimone, 1995).
As expected, maternal FAK was not depleted by FAK Mo, which was designed to block
translation of nascent transcripts. However, injection of FAK Mo at the one-cell stage did
reduce embryonic FAK levels by Stage 10.5 and FAK protein was nearly undetectable by
Western analysis in the morphants during cardiogenesis (Stage 28–39; Fig. 1A, B).
Densitometric analysis of Western blot band intensities demonstrated that FAK protein
expression in FAK morphant embryos was reduced by greater than 80% as compared with
controls by Stage 28 (Fig. 1C). FAK activity was also ablated in FAK-depleted embryos at
these stages as assessed by Western blotting for phospho-FAK with Y-397 antibody (data
not shown). Importantly, no changes in FAK expression were evident after injection of a
control five-base mismatch morpholino (data not shown). Moreover, Western blot analysis
for the protein tyrosine kinase, PYK2, demonstrated that FAK Mo did not disrupt the
translation of this closely related FAK family member (Fig. 1D).
FAK-Depletion Results in Abnormal Cardiac Morphogenesis
FAK morphant embryos exhibited a slight developmental delay beginning around Stage 10
but underwent normal gastrulation and neurulation as assessed by gross morphology (data
not shown). Furthermore, in situ hybridization analysis demonstrated that the mesodermal
markers, chordin, brachyury, and Myo-D were expressed in the appropriate spatiotemporal
pattern in both Con Mo- and FAK Mo-injected embryos at stages 10, 16, and 22 (Supporting
Information Fig. 1) suggesting that early mesodermal development was also unperturbed in
the FAK morphants. The lack of effect on these early developmental processes is not
surprising given that heterozygous FAK null mice are viable (Ilic et al., 1995) and that FAK
protein levels in our model system were not reduced by greater than 50% until after
commencement of these critical developmental stages (Fig. 1C).
Interestingly, by Stage 34, a large percentage of FAK-depleted embryos (79.6%) showed
pronounced pericardial edema (Fig. 1E and Table 1), indicating a morphogenetic cardiac
abnormality. Indeed, whole mount immunohistochemical staining of stage 39 hearts with
cardiac myosin heavy chain (MHC) or tropomyosin antibodies revealed marked dys-
morphogenesis in the majority of FAK morphant embryos. Although all hearts in Con Mo-
injected embryos were fully looped with three distinct chambers, FAK Mo-injected
embryonic hearts exhibited bent or twisted heart tubes that failed to fully undergo looping
(see Fig. 2). Other less penetrant phenotypes included anterior defects (such as decreased
head size), a shortened antero-posterior axis, and developmental arrest prior to Stage 30
(Supporting Information Table 1). Embryos that exhibited signs of these less frequent
abnormalities were excluded from subsequent analysis of cardiac morphology. Notably, all
FAK-depleted tadpoles died by Stage 42 indicating an essential role for FAK in Xenopus
development.
To further confirm that looping morphogenesis was dependent on FAK, we utilized a
phenotypic rescue approach. After aligning the sequences of Xenopus and chicken fak, we
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reasoned that FAK Mo would not interfere with chicken FAK translation, and subsequent in
vitro transcription/translation assays confirmed this assertion (data not shown). Thus, we
injected embryos at the one cell stage with either FAK Mo or a combination of FAK Mo and
2 ng chicken FAK capped-RNA (cFAK; denoted “rescue”) and assessed cardiac
morphology at Stages 37–39. Importantly, Western blot analysis confirmed that rescued
embryos expressed FAK protein at near endogenous levels (Fig. 2B). We next assessed
cardiac morphology using whole-mount MHC antibody staining and quantified properly
looped hearts. As shown in Figure 2C, D, expression of 2 ng cFAK induced a demonstrable
rescue of the morphant phenotype, as 67% of dually injected embryos exhibited normal
three-chambered hearts, compared to only 30% observed following injection of FAK Mo
alone. Collectively, these results demonstrate that FAK is required for appropriate
morphogenesis of the multichambered heart.
FAK Morphants Exhibit Appropriate Specification, Midline Migration, and Differentiation of
Cardiac Precursors
To define the FAK-dependent mechanisms involved in chamber morphogenesis, we
analyzed control and FAK-depleted hearts at various stages of development. As noted
above, the initial step of heart formation involves the bilateral movement of cardiac
progenitors (cardioblasts) to the ventral midline of the embryo where they fuse prior to
formation of the linear heart tube, a process that occurs between stages 28 and 32 in
Xenopus embryos. We performed in situ hybridization to examine the spatiotemporal
expression pattern of several cardioblast marker genes to determine whether the cardiac
precursors were specified and properly redistributed in the FAK morphants. The nkx2.5,
tbx5, and tbx20 expression domains of Con Mo- and FAK Mo-injected embryos were
comparable between Stages 26–32 and semiquantitative PCR analysis confirmed similar
transcript levels of these cardioblast markers in Con Mo- and FAK Mo-injected embryos at
Stages 30 and 32 (Fig. 3A, B and data not shown). Moreover, the myocyte differentiation
markers tropomyosin and troponin I were expressed at similar levels in FAK Mo- and Con
Mo-injected embryos as assessed by semiquantitative RT-PCR and immunohistochemistry
(Fig. 3C and data not shown). Indeed, 3D rendering of MHC-stained Stage 30 FAK
morphant embryos revealed a continuous sheet of myocytes, confirming appropriate
differentiation and fusion at the ventral midline (Fig. 3D). Moreover, despite subsequent
aberrant morphogenesis, FAK-depleted cardiac tissue exhibited normal rhythmic
contractions (data not shown). Collectively, these results indicate that specified cardiac
precursors migrated to the ventral mid-line and expressed markers of terminal differentiation
in a FAK-independent manner.
FAK Morphants Form Linear Heart Tubes but Fail to Undergo Appropriate Looping
Morphogenesis
Considering that the initial stages of cardiogenesis were not affected by FAK depletion, we
hypothesized that FAK may play an integral role in looping morphogenesis. To test this
possibility, we performed additional whole-mount tropomyosin antibody staining and
analyzed cardiac morphology using laser scanning confocal microscopy and 3D
isosurfacing. By Stage 32, when the heart tube is undergoing closure at the dorsal surface,
Con Mo- and FAK Mo- injected embryos appeared similar (Fig. 4A); however, analysis of
the dorsal aspect of the heart revealed that complete closure of the heart tube had not
occurred in FAK morphant embryos at this time (Supporting Information Fig. 2). Despite
this delay, all FAK morphant embryos analyzed at later stages exhibited fully closed heart
tubes (Supporting Information Fig. 2). However, analysis of FAK morphants at Stage 34
onward demonstrated a marked deficiency in heart tube looping. Indeed, the majority of
Stage 34 FAK morphant hearts exhibited a straight or only slightly bent appearance (Fig. 4B
and Supporting Information Fig. 2). Notably, injection with either Con Mo or five-base
Doherty et al. Page 4













mismatch morpholinos did not affect cardiac morphogenesis when compared with
uninjected embryos, indicating that the phenotypes observed were due to FAK depletion.
Myocyte Proliferation Is Reduced in FAK Morphant Heart Tubes
Since differential rates and/or locales of cell proliferation within the heart tube have been
correlated with appropriate looping morphogenesis (Ribeiro et al., 2007), we determined
whether cardiomyocyte proliferation was impaired in FAK-depleted embryos. To test this
possibility, we immunostained Con Mo- and FAK Mo-injected embryonic heart tubes for
tropomyosin and phospho-specific histone H3 (pH3) and imaged the hearts using laser
scanning confocal microscopy. As shown in Figure 5, we observed a significant decrease in
the total number of pH3-positive cardiomyocytes in pre-looped (Stage 32) FAK Mo hearts
relative to controls. Notably, pH3 staining in the surrounding noncardiac tissue was
comparable between Con Mo- and FAK Mo-injected embryos, indicating that FAK
depletion did not induce a global reduction in cellular proliferation (Fig. 5B). Double-
immunolabeling with tropomyosin and cleaved caspase 3 antibodies revealed no significant
difference in cardiomyocyte apoptosis between Con Mo-and FAK Mo-injected embryos
(Supporting Information Fig. 3), consistent with our previous findings that FAK depletion
does not induce apoptosis in developing mouse hearts (Hakim et al., 2007). Collectively,
these data indicate that the looping defect found in FAK morphant embryos may be due, at
least in part, to impaired cardiomyocyte proliferation.
FAK Regulates FGF-Dependent Myocyte Proliferation
Proper development of the myocardium is dependent on the close interaction with (and
signaling from) the endo- and epicardium. FGFs are potent regulators of embryonic myocyte
proliferation (Lavine and Ornitz, 2008; Lavine et al., 2008), and given evidence from our lab
that FAK activity is required for FGF-induced Map kinase signaling (DiMichele et al., 2009)
and that inactivation of FAK phenocopies the noncompaction defects observed in FGF
Receptor 1 (FGFR1) knock-out mice, we reasoned that FAK may play a major role in
regulating cardiac morphogenesis mediated by epicardial-derived FGFs.
To test whether FGF signaling was required for Xenopus heart looping, we treated embryos
with a selective FGFR1 tyrosine kinase inhibitor, SU5402 (Langdon et al., 2007;
Mohammadi et al., 1997). As shown in figure 6, continuous exposure of embryos to SU5402
(50 μM) during cardiogenesis (Stages 25–37) resulted in small and dysmorphic hearts,
although the embryos appeared relatively normal in size and shape (Fig. 6A, B).
Importantly, the hearts of the SU5402-treated embryos resemble the FAK morphant hearts
in that they fail to undergo looping (Fig. 6B and Table 2). This phenotype was highly
penetrant (observed in 94% of treated embryos) while no looping defects were observed in
embryos treated with DMSO (vehicle). These data indicate that both FGF- and FAK-
dependent signals play an important role in coordinating chamber growth and
morphogenesis.
To determine whether FAK might coordinate mitogenic cues initiated by FGF, we first
determined whether FGF stimulates FAK activity in rat primary cardiomyocytes in culture.
Importantly, Western blot analysis showed that basic fibroblast growth factor (bFGF)
induced a marked increase in FAK activity in cardiomyocytes and that SU5402,
dramatically reduced this response (Fig. 7A). It is well established that the endogenous FAK
inhibitor, FAK-related non-kinase (FRNK), can serve as a dominant interfering mutant that
downregulates FAK-mediated signaling pathways (Richardson and Parsons, 1996). We
previously generated FRNK adenoviruses that are well-suited for studying FAK-dependent
processes in cultured cardiomyocytes. Therefore, to determine whether FAK was essential
for FGF-stimulated myocyte proliferation, we infected embryonic rat cardiomyocytes with
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10 multiplicity-of-infection (m.o.i) green fluorescent protein (GFP) or GFP-FRNK
adenovirus (Fig. 7B) and examined the rate of proliferation of these cells in serum-free (SF)
medium in the absence or presence of bFGF. GFP and GFP-FRNK were efficiently
expressed in 100% of the cardiomyocyte population as determined by immunofluorescence
(data not shown). Under these conditions, bFGF induced the rate of 5-bromo-2-deoxyuridine
(BrdU) incorporation in GFP-infected cells by ~20%, whereas only 4% of FRNK-infected
cells were BrdU-positive (Fig. 7C). Collectively, these data indicate that FAK activity is
necessary for mediating FGFR-dependent cardiomyocyte proliferation, an event that may
control both looping morphogenesis and growth of the embryonic heart.
DISCUSSION
Previous studies have demonstrated an essential role for FAK during embryonic
development in mice but not flies (Grabbe et al., 2004; Ilic et al., 1995). FAK null mice
exhibit general cardiovascular defects that were not reported in FAK-depleted Drosophila. A
major notable difference between the cardiovascular systems of these two species is that
Drosophila contains a simple linear heart tube that does not undergo looping morphogenesis.
Although recent studies in myocyte-restricted FAK-depleted mouse hearts revealed that
FAK is necessary for growth of the four chambered heart (DiMichele et al., 2009; Peng et
al., 2008), no studies to date have addressed a role for FAK in regulating cardiac looping.
Our current findings show that FAK-depleted Xenopus embryos exhibit pronounced
pericardial edema, cardiac dysmorphogenesis, and embryonic death. Temporal assessment
of cardiac morphogenesis revealed that FAK depletion did not affect the midline migration
or differentiation of cardiac precursors. However, depletion of FAK markedly reduced
proliferation in prelooped hearts in comparison to stage-matched controls and induced a
profound defect in looping morphogenesis.
We found that FAK-depleted Xenopus embryos died by Stage 42, which is relatively late in
development in comparison to FAK-depleted mice (E8-10.5). Prolonged survival in FAK-
depleted Xenopus may be due, in part, to the enhanced nutrient exchange that is known to
permit uncoupling of heart and embryonic development in this species until late tadpole
stages. However, it is also possible that the presence of maternal FAK (which is refractory to
the FAK morpholino) may have been sufficient to drive early FAK-dependent
morphogenetic processes in the studies presented herein. Indeed, we found a low level of
maternal FAK protein in both Con Mo- and FAK Mo-injected embryos until at least stage
10.5 (the onset of gastrulation), consistent with previous studies of FAK expression during
Xenopus development (Hens and DeSimone, 1995). Therefore, while FAK-depleted
Xenopus embryos gastrulate and neurulate normally, the role of FAK in gastrulation has not
been addressed in this study. Nonetheless, the translation of embryonically expressed FAK
protein was dramatically reduced in the FAK morphants from Stage 10.5 onwards, and FAK
protein was nearly undetectable in these embryos during cardiogenesis. Thus, our findings
that the migration of specified cardioblasts from the bilateral heart fields to the ventral
midline and their differentiation into mature cardiomyocytes was not altered in the FAK
morphants, indicates that these processes are both FAK-independent.
The finding that cardioblast migration was FAK-independent was somewhat surprising
given that several published studies from our laboratory and others have indicated that FAK
is essential for cell motility (Parsons, 2003). Notably, we previously showed that directional
motility of cardiomyocytes requires FAK (Hakim et al., 2007). Moreover, previous studies
in zebrafish have revealed that the coordinated motility of cardioblasts to the midline is
regulated by fibronectin (Trinh and Stainier, 2004b) and studies in Drosophila revealed a
strong genetic interaction between the Drosophila β1 integrin and the guidance cue, Slit, in
regulating cardioblast movement (Engel et al., 2005; MacMullin and Jacobs, 2006).
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However, consistent with our finding that midline fusion of cardioblasts occurs normally in
FAK-depleted Xenopus embryos, MacMullin et al. found no phenotypic interaction between
FAK and Slit (MacMullin and Jacobs, 2006), leading us to reason that distinct integrin-
induced signals regulate cardioblast and cardiomyocyte motility. Indeed, cardioblast motility
involves a sheet-like movement that is known to be dependent on cell-cell interactions,
whereas we have shown that myocytes exhibit directional motility that requires FAK-
dependent lamellipodial protrusions (Hakim et al., 2007). While previous studies have
indicated a role for FAK in scratch wound closure of a confluent monolayer of fibroblasts
(Hsia et al., 2003; Sieg et al., 1999) we have found that FAK is not necessary for wound
closure in smooth muscle cells, indicating that the mechanisms that regulate sheet-like
movements may be cell type specific (unpublished observations, JMT).
Our mechanistic studies herein indicate that FAK is essential for regulating myocyte
proliferation within the developing heart tube. We found that FAK morphant hearts
exhibited a decrease in mitotically active myocytes relative to controls prior to looping. This
finding is significant because recent studies in zebrafish have demonstrated that looping
morphogenesis is associated with a shift from homogeneous proliferation to increased
proliferation within the presumptive atrial and ventricular chambers (Ribeiro et al., 2007).
Several studies suggest that members of the FGF family (Itoh and Ornitz, 2004), including
FGF-1 (Engelmann et al., 1991, 1993), bFGF (David et al., 2003; Pasumarthi et al., 1996),
and FGF9 (Lavine et al., 2005) are critical endoderm-derived mediators of myoycte
proliferation during myocardial development. Interestingly, our previous studies indicated
that myocyte-restricted inactivation of FAK in mice phenocopies the noncompaction defects
observed in mice with myocyte-restricted deletion of FGFR-1 and FGFR-2 (DiMichele et
al., 2009). We now show that inhibition of either FAK or FGFR signaling in Xenopus leads
to a failure of heart looping, that FGF stimulates FAK activity, and that FAK activation is
necessary for FGFR-dependent myocyte proliferation in vitro. Since SU-5402 is an effective
inhibitor of FGFR1, we hypothesize that FGFR1-dependent FAK activation is necessary for
heart looping. However, it is formally possible that this compound may also inhibit other
FGF receptor subtypes including FGFR4 and FGFR2 which have been reported to be
expressed at higher levels than FGFR1 in the developing Xenopus heart (Lea et al., 2009).
In terms of signaling, FGF receptors are linked to the MAPK signaling pathways which
terminate in activation of ERK, c-Jun N-terminal kinase, and p38. Interestingly, several
recent studies have indicated that p38 may function at the G2/M checkpoint to block
cardiomyocyte cell cycle progression (Engel et al., 2005, 2006) and we recently showed that
expression of FRNK (or inactivation of FAK) promotes p38 activity and regulates
expression of the p38-dependent cell cycle modifier, p27kip (DiMichele et al., 2009). Thus,
we hypothesize that FGFR-stimulated FAK activation leads to p38 repression and induction
of the proliferative signals that may be necessary to drive looping morphogenesis.
Although FGFs provide mitogenic signals to embryonic cardiomyocytes, recent evidence in
zebrafish indicates that FGFs are also necessary for recruitment and differentiation of the
secondary heart field (SHF) (de Pater et al., 2009). This population of cells contributes to
right ventricle and outflow tract formation in zebra-fish, chick, and mouse hearts, and was
also recently identified in Xenopus (Brade et al., 2007; de Pater et al., 2009; Martinsen et al.,
2004; Sadaghiani and Thiébaud, 1987). Although the precise timing and extent of SHF
contribution during frog heart development remains unclear, studies performed in chick and
mouse indicate that SHF is not typically recruited until after looping morphogenesis (de
Pater et al., 2009; Martinsen et al., 2004; Sadaghiani and Thiébaud, 1987). Thus, while it is
formally possible that the abnormal morphogenesis observed in FAK morphant hearts may,
in part, arise from a defect in this FGF-dependent process, this is unlikely the primary cause
of dysmorphogenesis, since FAK morphants exhibit defects in prelooped heart tubes.
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In summary, our studies are the first to indicate that FAK is necessary for viability and
cardiogenesis in Xenopus. FAK-depleted cardiac precursor cells migrated to the ventral
midline, fused, and formed a linear heart tube. However, FAK morphant heart tubes
exhibited a marked reduction in proliferating myocytes and a concomitant failure to undergo
looping. Our studies in cultured cardiomyocytes confirmed that FAK regulates myocyte
proliferation in a cell autonomous fashion and that FAK acts downstream of FGFRs to
regulate this critical function.
MATERIALS AND METHODS
Embryo Culture and Microinjection
Preparation and injection of X. laevis embryos was carried out as previously described
(Wilson and Hemmati-Brivanlou, 1995). Staging was performed according to Nieuwkoop
and Faber (Nieuwkoop and Faber, 1994). Antisense morpholino oligonucleotides were
designed against either the start site (xFAKst Mo) or the 5′-untranslated region (xFAKup
Mo) of Fak. Sequences used were: xFAKup, 5′CTG ATG CTA GGT GTC TGT CAT ATT
C 3′ and xFAKst, 5′TCC AGG TAA GCC GCA GCC ATA GCC T 3′. We utilized two
control morpholinos, a five-base mismatched morpholino, in which five nucleotides of the
xFAKup Mo sequence were changed such that the morpholino no longer reacted with
Xenopus fak, and a standard control morpholino (Con Mo) (Gene Tools, Philomath, OR).
Morpholinos were injected at a concentration of 40 ng/embryo at the one-cell stage, except
where indicated. All in vivo data shown herein represent experiments performed with
xFAKup (hereafter referred to as FAK Mo). Similar results were obtained with xFAKst Mo
(data not shown).
Capped chicken FAK RNA used for rescue experiments was first generated using the
mMessage/mMa-chine capped RNA kit (Ambion), according to the manufacturer’s
instructions. RNA was quantified by spectrophotometry and diluted in RNase-free water.
For overexpression, RNA was microinjected at a concentration of 2 ng/embryo in a 10 nL
injection volume. For rescue experiments, FAK capped-RNA was mixed with FAK Mo in
order to achieve 40 ng FAK Mo and 2 ng FAK capped-RNA per embryo (10 nL injection
volume).
Inhibitor Treatments
Embryos for inhibitor experiments were cultured in normal culture media until stage 25, at
which time the culture media was supplemented with 2.5 mM dimethyl sulfoxide (DMSO)
or 50 μm SU5402 (Pfizer) (Langdon et al., 2007). Embryos were cultured under these
conditions until Stage 37 and processed for immunohisto-chemical analysis to analyze heart
morphology.
In Vitro Transcription/Translation Assays
In vitro transcription/translation assays were performed using the TnT Quick-Coupled
Transcription/Translation System according to the manufacturer’s instructions (Promega,
Madison, WI).
Whole Mount-Immunohistochemistry and In Situ Hybridization
Embryos were prepared for whole-mount immunohistochemistry by fixation in Dent’s
fixative (80% methanol/20% dimethyl sulfoxide) or 4% paraformaldehyde and were then
processed as previously described (Kolker et al., 2000), except that the rehydration steps
were omitted for embryos fixed in paraformaldehyde. Fixed embryos were incubated
overnight at 4°C with a primary antibody against α-myosin heavy chain (α-MHC) (Abcam,
Cambridge, MA) (1:500), tropomyosin (DSHB, Iowa City, Iowa) (1:200), phospho-Histone
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H3 (pH3) (1:250) (Millipore, Billerica, MA), or cleaved caspase 3 (1:250) (Cell Signaling,
Danvers, MA). Embryos were then washed and incubated overnight at 4°C with the
appropriate Cy-3 or Alexa-488 conjugated secondary antibodies (1:200) and Topro-3
(1:1,000) (Molecular Probes, Carlsbad, CA) to stain the nuclei.
Whole-mount in situ hybridization was performed as previously described (Harland, 1991).
Plasmids for MyoD, chordin, xBra, NKX2.5, TBX5, and Tbx20 were linearized and used to
generate digoxigenin-UTP-labeled (Roche, Mannheim, Germany) antisense RNA probes
using the appropriate restriction endonuclease and polymerase. Color detection was
determined by BM Purple substrate (Roche) after incubation with alkaline-phos-phatase
conjugated antidigoxigenin antibody.
Western Blot Analysis
Embryos (n = 5–10) were snap-frozen in liquid nitrogen and protein lysates were generated
as previously described (Kragtorp and Miller, 2006). Briefly, 5–10 embryos were lysed by
brief (1–2 s) sonication in a modified RIPA buffer (10 mM Tris pH 7.5, 100 mM NaCl, 1
mM EDTA, 1 mM EGTA, 20 mM Na4P2O7, 1% Triton X-100). Cardiomyocytes were lysed
in modified radioimmune precipitation assay buffer (50 mM Hepes, 0.15 M NaCl, 2 mM
EDTA, 0.1% Nonidet P-40, 0.05% sodium de-oxycholate, pH 7.2). Each lysis buffer
contained a cocktail of protease and phosphatase inhibitors including 1 mM Na3VO4, 40
mM NaF, 10 mM Na2 pyrophosphate, 100 μM leupeptin, 1 mM 4-(2-
aminoethyl)benzenesulfonyl fluoride hydrochloride, 0.02 mg/mL soybean trypsin inhibitor,
and 0.05 trypsin inhibitory units/mL aprotinin. Samples were clarified by centrifugation
twice at 14,000g at 4°C and the supernatant was retained. Fifty micrograms of total protein
was boiled in sample buffer and loaded onto a 10% SDS-acrylamide gel. Separated proteins
were transferred onto nitrocellulose, blocked in 5% dry milk in Tris-Buffered Saline (TBS)
+ 0.1%Tween (TBST), and incubated overnight with primary antibody diluted in blocking
solution. The following antibodies were utilized at a dilution of 1:1,000: FAK Clone 4.47
(Millipore), phospho-FAK Y397 (Invitrogen, Carlsbad, CA), PYK2 (Cell Signaling), and
ERK-CT (Millipore). Blots were incubated with the appropriate horseradish peroxidase-
conjugated secondary antibodies (1:2000 dilution) (GE Healthcare, Piscataway, NJ) and
proteins were visualized by chemiluminescence (Thermo Scientific, Rockford, IL).
Densitometry of Western blot band intensities was performed using ImageJ 1.37v software
(NIH).
RT-PCR Analysis
RNA was isolated from 10 embryos following lysis in Trizol according to the
manufacturer’s specifications (Invitrogen). Reverse transcription reactions were performed
using the iScript cDNA kit (Bio-Rad, Hercules, CA) and PCR reactions were performed
using ExTaq polymerase (Takara Bio, Japan) following previously published primer sets
and cycling parameters (Meadows et al., 2008; Small et al., 2005). Histone H4 primers were
as follows: Forward 5′GGG ATA ACA TTC AGG GTA TC 3′ and Reverse 5′CAT GGC
GGT AAC TGT CTT C 3′.
Myocyte Cell Isolation, Culture, Infection, and Treatment
Cardiomyocytes were isolated from embryonic Day 13.5 (E13.5) rats with trypsin and
collagenase digestion and were purified as described previously (Taylor et al., 2000). The
cells were re-suspended in medium containing a 4:1 mixture of Dulbecco’s Modified Eagle
Medium (DMEM):Media 199 containing 10% fetal calf serum and 1% penicillin-
streptomycin and plated on tissue culture plastic for two consecutive 1-h periods to remove
non-cardiomyocyte cells, resulting in cultures with >95% myocytes. The cardiomyocytes
were then plated on tissue culture dishes precoated with fibronectin (10 μg/mL). For
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adenoviral infection, cells were infected with replication-defective Ad5-GFP or GFP-FRNK
at a concentration of 10 multiplicity of infection (m.o.i) for the indicated times in serum-
containing media. Cells were then serum starved overnight and treated for the indicated
times with FGF-2 (100 ng/mL) or vehicle. 5-bromo-2-deoxyuridine (BrdU) labeling was
performed as previously described (DiMichele et al., 2009). The FGF-receptor 1 (FGFR1)
inhibitor, SU-5402, was a generous gift from Pfizer (Kalamazoo, MI).
Widefield and Laser Scanning Confocal Microscopy, Image Deconvolution, and 3D
Rendering
Embryos were cleared for microscopic analysis in 2:1 benzyl benzoate:benzyl alcohol and
placed on a glass coverslip. Embryos were analyzed by widefield microscopy using a Leica
MZFLIII fluorescence dissecting scope or Olympus IX81 microscope or by confocal
microscopy using an Olympus FV500 laser scanning confocal microscope (Olympus, USA)
and Fluoview v5.1 software. Confocal z-stacks were obtained using a 1.24 μm step-size. Z-
series stacks were deconvolved using Auto-deblur Gold v. X.1.4.1 software (Autoquant,
Media Cybernetics, Bethesda, MD). Deconvolved images were then imported to Imaris x64
6.1.5 software (Bitplane AG, St. Paul, MN) for 3D rendering and isosurfacing.
To assess proliferation and apoptosis in Xenopus hearts, we immunostained embryos for
tropomyosin (to label cardiomyocytes) and either pH3, to label proliferating cells, or cleaved
caspase-3, to label cells undergoing apoptosis. Z-stack images of each heart were obtained
by laser scanning confocal microscopy and each optical slice was examined individually
throughout the thickness of the heart. Each cell that was immunoreactive for both
tropomyosin and pH3 or cleaved caspase 3 was scored as a positive cardiomyocyte. In order
to ensure that cells were not counted twice, we confirmed our results by counting all double-
immunoreactive cells from optical sections that were 12 steps (14.88 μm) apart (the
approximate size of the embryonic myocyte). The surface area of the heart (μm2) was
calculated by isosurfacing the tropomyosin positive area using Imaris software. This
calculated value was then multiplied by 28 μm (the average thickness of the heart wall at
this stage of development), to determine total heart volume (μm3). Total noncardiomyocytes
were scored and compared to the volume of the tissue section analyzed. Statistical analyses
were performed using a two-tailed t-test (two-sample, equal variance-homoscedastic).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Depletion of FAK in Xenopus laevis leads to pericardial edema. A: FAK or Control
morpholinos (20 and 40 ng) were injected into fertilized oocytes and embryonic FAK
protein levels were assessed at the indicated stages by Western blotting. Levels of ERK are
shown as a control for loading. B: Western blot analysis for FAK in Con Mo- and FAK Mo-
injected embryos (40 ng/embryo) at the indicated stages of development. Levels of ERK are
shown as a control for loading. C: Densitometric analysis of Western blots comparing FAK
band intensity relative to ERK. Data are presented as FAK levels in FAK Mo-embryos
relative to Con Mo-embryos (set to 1) at each developmental stage analyzed. D: Western
blot analysis for PYK2 (and ERK) in stage 30 Con Mo- and FAK Mo-injected embryos. E:
Gross morphology of Control and FAK morphant tadpoles at Stage 37. FAK morphants
exhibit a slightly shortened anteroposterior axis and pericardial edema (arrow).
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FAK morphant embryos exhibit marked cardiac dysmorphogenesis. A: Lateral view of
whole-mount immunohistochemistry for tropomyosin reveals a fully looped three-
chambered heart in Con Mo-injected embryos while those injected with FAK Mo appear
distended and partially looped (middle panel) or unlooped (right panel). Anterior is to the
left and dorsal toward the top in all panels. Regions of interest are labeled as follows: i,
inflow tract; v, ventricle; o, outflow tract. B: Western blot analysis for FAK in uninjected,
Con Mo-injected, FAK Mo-injected, and rescue embryos at Stage 37. Levels of ERK are
shown as a control for loading. C: Lateral view of whole-mount immunohisto-chemistry for
MHC reveals rescue of the FAK morphant phenotype is achieved by coexpression of 2 ng
chicken FAK. D: Heart morphology analysis of Con Mo-injected, FAK Mo-injected, rescue
(FAK Mo and 2 ng chicken FAK co-injection), and 2 ng chicken FAK alone demonstrates
that while FAK morphant embryos exhibit full looping in only 30% of embryos examined,
rescue embryos exhibit full looping morphology in 67%. Total number of embryos analyzed
were n = 27 (Con Mo), n = 34 (FAK Mo), n = 42 (Rescue), n = 20 (2 ng c-FAK), collected
from two separate experiments.
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FAK depletion does not impact cardiac specification or differentiation. A: In situ
hybridization of Stage 30 embryos for TBX5 and NKX2.5. Ventral views (left panels) are
oriented with anterior toward the top, lateral views (right panels) are oriented with anterior
to the left and dorsal to the top. B, C: RT-PCR analysis at Stages 30 (left panels) and 32
(right panels) for TBX5, TBX20, NKX2.5 (B), and tropomyosin (tm), and Troponin T (TnT)
(C). Histone H4 (H4) serves as a control. Data represent results from 10 embryos per
condition and experiments were repeated at least twice. D: Ventral and front views of
whole-mount immunohistochemistry for MHC reveals a continuous and fused sheet of
differentiated myocytes at the ventral midline (indicated by white arrow) in FAK Mo-
injected embryos. Images represent 3D reconstructions of confocal z-stack sections.
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FAK depletion impairs looping morphogenesis. Whole mount immunohisto-chemical
staining for tropomyosin was performed on Stage 32 (A), and 34 (B) embryos that were
injected with either Con Mo (left) or FAK Mo (right) at the one-cell stage. Images represent
3D reconstructions of confocal z-stack sections (top) and Imaris isosurfacing (bottom).
Stage 32 view is from the posterior looking through the heart tube toward the anterior end;
dorsal is to the top. Stage 34 view is lateral with anterior to the left, dorsal to the top. Note
that looping is perturbed in Stage 34 FAK morphants. Arrows point to region of interest
where the heart takes on a spiral shape indicative of looping morphogenesis.
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Myocyte mitosis is attenuated in FAK morphant heart tubes. A: Whole mount
immunohistochemical staining for tropomyosin (green) and phospho-Histone H3 (red) was
performed on prelooped (Stage 32) embryos that were injected with either Con Mo (left) or
FAK Mo (right) at the one-cell stage. Images represent 3D reconstructions of confocal z-
stack sections (top panels) or a single optical section (bottom panels). B: Total number of
pH3 positive myocytes and noncardiac cells were counted in each optical section of Con
Mo- and FAK Mo-injected embryos (19 embryos were analyzed per condition, collected
from at least three separate experiments).
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Treatment with the FGFR1-inhibitor, SU5402, impairs cardiac looping. Widefield
microscopic analysis (A) of gross morphology of untreated control, DMSO-treated (2.5
μM), or SU5402-treated (50 μM) embryos at Stage 37 reveals that SU5402 treatment
induces edema in the middle-ventral region of the embryo (top right panel) or pericardial
edema (bottom right panel) in some embryos. Arrows point to regions of edema. B: Lateral
view of whole-mount immunohistochemistry for MHC reveals a fully looped three-
chambered heart in untreated and DMSO-treated embryos while those treated with SU5402
appear unlooped. Anterior is to the left and dorsal is to the top in all panels. Total number of
embryos analyzed for heart morphology were: n, 22 (untreated), n = 34 (DMSO), and n = 35
(SU5402) and were collected from three separate experiments.
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FAK is activated by FGF and is necessary for FGF-dependent myocyte proliferation. A:
Western blot analysis of cell lysates isolated from primary embryonic rat cardiomyocytes.
Cells were maintained in serum free (SF) media and treated with bFGF (100 ng/mL) or
vehicle (veh.) for 30 min with or without 10 min pretreatment with the specific FGFR-
inhibitor, SU5402 (10 μM). Lysates were immunoblotted with antibodies directed towards
phospho-specific Y397-FAK or total FAK. B: BrdU incorporation in isolated embryonic
cardiomyocytes infected with GFP- or GFP-FRNK adenovirus (10 m.o.i). Cells were
maintained in serum-free medium and treated with vehicle (not shown) or bFGF (100 ng/
mL) for 24 h. Costaining with anticardiac troponin T (cTnT) was performed to identify
cardiomyocytes. C: Quantification of BrdU- positive cardiomyocytes (means ± SEM; N = 3;
minimum of 300 cells/condition). Scale bar is 20 μm.
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Table 1
FAK Depletion Leads to Marked Pericardial Edema
Con Mo FAK Mo
Trial 1 0%(n = 51) 85.2% (n = 27)
Trial 2 2.5% (n = 79) 92.3% (n = 78)
Trial 3 4%(n = 26) 61.4% (n = 44)
Embryos were scored for pericardial edema between Stages 34 and 39 in three separate trials.
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Table 2
Treatment With SU5402 Causes Defects in Cardiac Looping Morphology
Phenotypic analysis after treatment with SU5402
Treatment (No. of Embryos) Untreated (n = 22) DMSO (n = 34) SU5402 (n = 35)
Anterior defect 0 (0%) 1 (3%) 1 (3%)
Middle–ventral region edema 0 (0%) 0 (0%) 4 (11%)
Pericardial edema 0 (0%) 0 (0%) 12 (34%)
Unlooped heart 0 (0%) 0 (0%) 33 (94%)
Embryos were scored for gross morphology in three separate experiments. As shown, SU5402 induced edema and cardiac looping defects. Several
embryos exhibited both edema and an unlooped heart, therefore the totals do not add up to 100%.
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